phosphoserine has been researched along with Carcinoma, Lewis Lung in 3 studies
Phosphoserine: The phosphoric acid ester of serine.
Carcinoma, Lewis Lung: A carcinoma discovered by Dr. Margaret R. Lewis of the Wistar Institute in 1951. This tumor originated spontaneously as a carcinoma of the lung of a C57BL mouse. The tumor does not appear to be grossly hemorrhagic and the majority of the tumor tissue is a semifirm homogeneous mass. (From Cancer Chemother Rep 2 1972 Nov;(3)1:325) It is also called 3LL and LLC and is used as a transplantable malignancy.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jackson, JL | 2 |
| Young, MR | 3 |
| Liu, SW | 1 |
| Meisinger, J | 1 |
3 other studies available for phosphoserine and Carcinoma, Lewis Lung
| Article | Year |
|---|---|
Protein phosphatase-2A modulates the serine and tyrosine phosphorylation of paxillin in Lewis lung carcinoma tumor variants.
Topics: Animals; Carcinoma, Lewis Lung; Cell Movement; Cytoskeletal Proteins; Enzyme Inhibitors; Focal Adhes | 2002 |
Protein phosphatase-2A restricts migration of Lewis lung carcinoma cells by modulating the phosphorylation of focal adhesion proteins.
Topics: Animals; Birds; Blotting, Western; Carcinoma, Lewis Lung; Cell Movement; Cytoskeletal Proteins; Down | 2003 |
Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.
Topics: Animals; Blotting, Western; Carcinoma, Lewis Lung; Cytoskeletal Proteins; Down-Regulation; Enzyme In | 2003 |